Records containing: Ovarian Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-10-27A Phase II Study of Sunitinib in Patients With Refractory or Relapsed Germ Cell Tumors
-
CLINICAL_TRIALS study record update · 2015-10-26A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
-
CLINICAL_TRIALS study record update · 2015-10-20A Two-part Phase 1/2a, Open-label, Dose Escalation Study to Evaluate the Tolerability and Preliminary Antitumour Activity of OPB-111001 in Patients With Advanced Cancers That Are Poorly Responsive to Standard Anticancer Treatment
-
CLINICAL_TRIALS study record update · 2015-10-19Phase II Study of Irinotecan in Combination With Bevacizumab for the Treatment of Recurrent Ovarian Cancer.
-
CLINICAL_TRIALS study record update · 2015-10-14A Phase 1b Open-Label, Multi-Center Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With High-Risk Stage I and Stages II-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-10-12Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2015-10-09Improving the Quality of Advanced Cancer Care With Disease Management
-
CLINICAL_TRIALS study record update · 2015-10-08A Randomized, Double Blind, Placebo-Controlled Trial of Celecoxib in Patients With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2015-10-07The Elizabeth Registry for Low Grade Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2015-09-29A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2015-09-28A Multicenter Randomized Phase II Study of Docetaxel/Carboplatin Versus Docetaxel/Pegylated Liposomal Doxorubicin as Second Line Treatment in Patients With Platinum Sensitive Disease
-
CLINICAL_TRIALS study record update · 2015-09-24A Pilot Program to Personalize Care by Integrating Traditional and Complementary Medicine for Women With Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2015-09-23A Randomised, Placebo-controlled, Trial of Concurrent Cediranib [AZD2171] (With Platinum-based Chemotherapy) and Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2015-08-25A Phase II Evaluation of Panitumumab and Gemcitabine as Treatment for Women With Recurrent Epithelial Ovarian Cancer.
-
CLINICAL_TRIALS study record update · 2015-08-05A Randomized Phase III Study Comparing Upfront Debulking Surgery Versus Neo-Adjuvant Chemotherapy in Patients With Stage IIIC or IV Epithelial Ovarian Carcinoma
-
CLINICAL_TRIALS study record update · 2015-07-23A Phase II Study of UCN-01 in Combination With Topotecan in Patients With Advanced Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2015-07-07Phase II Study of Bevacizumab and Doxil in the Treatment of Platinum-Resistant or Refractory Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2015-07-07International, Prospective, Open-label, Multicenter, Pharmacoepidemiological Study to Determine Predictors of Clinical Outcomes in Chemotherapy-treated Cancer Patients at Risk for Febrile Neutropenia and Treated Prophylactically With Filgrastim Biosimilar.
-
CLINICAL_TRIALS study record update · 2015-07-03A Randomized Phase II Trial of Avastin (A) or Avastin and Erlotinib (AE) as First Line Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Newly Diagnosed Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors
-
CLINICAL_TRIALS study record update · 2015-06-29Phase I Evaluation of Intravenous Carboplatin With Weekly Paclitaxel and Bevacizumab in Patients Undergoing Neoadjuvant Chemotherapy for Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2015-06-23A Phase II, Open-label, Multicenter Study to Evaluate the Effect of Tumor-based HER2 Activation on the Efficacy of rhuMAb 2C4 (Pertuzumab) in Subjects With Advanced, Refractory or Recurrent Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2015-06-18Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study
-
CLINICAL_TRIALS study record update · 2015-06-17A Phase II Study of Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer
-
CLINICAL_TRIALS study record update · 2015-06-11The Effect of Tai-chi/Qi-gong on Quality of Life (QOL), Sleep, and Fatigue in Patients With Gynecological Malignancies
-
CLINICAL_TRIALS study record update · 2015-06-10Veliparib (ABT888) and Topotecan (Hycamtin®) for Patients With Platinum-Resistant or Partially Platinum-Sensitive Relapse of Epithelial Ovarian Cancer With Negative or Unknown BRCA Status